Sign in
4/A

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-23-008098

CEO acquired 31,440 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Shah Gaurav · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-02-14 Exercise or conversion : show line 1 in the form +31,440 549,079 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2023-02-14 Grant or award : show line 2 in the form Stock Option (Right to Buy) +348,590 348,590 D
2023-02-14 Grant or award : show line 3 in the form Restricted Stock Units +116,317 116,317 D
2023-02-14 Exercise or conversion : show line 4 in the form Restricted Stock Units +31,440 63,835 D
Loading xslF345X03/form4.xml…